Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus versus tacrolimus with mycophenolate mofetil after kidney transplantation
2007-006763-77Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Mar 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in kidney transplant comparing Sirolimus + mycophenolate mofetil with Tacrolimus + mycophenolate mofetil (2 arms). Primary endpoint: Composite treatment failure at 2 years. Started Mar 2008; status: active.
02
Drugs
sirolimustacrolimusmycophenolate mofetil
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2007-006763-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006763-77.